PACB vs RF
Pacific Biosciences of California (PACB) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
RF (RF) common stock.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
RF does not have a complete income-statement cache yet.
PACB currently screens at market cap $387.1M. RF currently screens at market cap $0.
Not investment advice. Open the PACB and RF stock pages for the full models.
Not investment advice.